Derek L. Stirewalt

发表

Quantitative and stoichiometric analysis of the microRNA content of exosomes

Muneesh Tewari, Celestia S. Higano, Colm Morrissey, 2014, Proceedings of the National Academy of Sciences.

Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia

J. Radich, D. Stirewalt, Jerald P. Radich, 2000 .

The role of FLT3 in haematopoietic malignancies

J. Radich, D. Stirewalt, Derek L. Stirewalt, 2003, Nature Reviews Cancer.

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

I. Bernstein, J. Radich, J. Buckley, 2001, Blood.

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

Emily A. Stevens, J. Radich, B. Wood, 2020, Biomarker Research.

Receptor tyrosine kinase alterations in AML - biology and therapy.

S. Meshinchi, D. Stirewalt, Derek L. Stirewalt, 2010, Cancer treatment and research.

Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.

J. Radich, B. Wood, S. Meshinchi, 2017, Biopreservation and biobanking.

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.

Erik Andries, Donna P Ankerst, Huining Kang, 2006, Blood.

Identification of genes with abnormal expression changes in acute myeloid leukemia

Soheil Meshinchi, J. Radich, S. Heimfeld, 2008, Genes, chromosomes & cancer.

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.

S. Raimondi, J. Radich, N. Heerema, 2009, Blood.

Clinical implications of FLT3 mutations in pediatric AML.

J. Radich, N. Heerema, S. Meshinchi, 2006, Blood.

Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms: A Phase 1/2 Study

E. Estey, E. Pogosova-Agadjanyan, M. Othus, 2017, Leukemia.

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies

C. Bloomfield, H. Gundacker, S. Raimondi, 2006, Leukemia.

Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.

E. Estey, J. Radich, S. Meshinchi, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.

Thomas M. Schmitt, I. Weissman, K. Loeb, 2012, Blood.

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

E. Kroh, P. S. Mitchell, M. Tewari, 2011, Proceedings of the National Academy of Sciences.

Sample processing obscures cancer-specific alterations in leukemic transcriptomes

H. Dvinge, R. Ries, R. Bradley, 2014, Proceedings of the National Academy of Sciences.

Circulating microRNAs as stable blood-based markers for cancer detection

Daniel B. Martin, R. Gentleman, P. Nelson, 2008, Proceedings of the National Academy of Sciences.

Gene expression changes in normal haematopoietic cells.

D. Stirewalt, J. Lionberger, Derek L. Stirewalt, 2009, Best practice & research. Clinical haematology.

Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome

J. Abkowitz, O. Abdel-Wahab, R. Bradley, 2021, Blood.

NCCN Senior Adult Oncology , Version 2 . 2014 Clinical Practice Guidelines in Oncology

H. Cohen, R. Jagsi, N. Keating, 2014 .

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis

J. Radich, O. Abdel-Wahab, R. Levine, 2023, Blood advances.

Molecular alterations of the IDH1 gene in AML: a Children’s Oncology Group and Southwest Oncology Group study

I. Bernstein, S. Raimondi, J. Radich, 2010, Leukemia.

Transcriptome Profiling of Pediatric Core Binding Factor AML

Ying Hu, Qingrong Chen, R. Ries, 2015, PloS one.

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

J. Radich, S. Meshinchi, D. Stirewalt, 2023, Biomarker Research.

Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency

Thomas M. Schmitt, J. Bielas, M. Bar, 2022, Science Translational Medicine.

Antibodies to N‐terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated

D. Stirewalt, C. Elkins, N. Carbonetti, 1992, Molecular microbiology.

NCCN: Continuing Education

H. Cohen, C. Gross, R. Jagsi, 2021 .

Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .

H. Cohen, R. Jagsi, N. Keating, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia by Enhancing Common β Chain Cytokine Receptor Endocytosis.

Kristofer C. Berrett, S. Varambally, J. Radich, 2021, Blood.

Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling*

Jeffrey R. Whiteaker, Uliana J. Voytovich, Jacob J. Kennedy, 2015, Molecular & Cellular Proteomics.

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia.

H. Gundacker, J. Radich, S. Heimfeld, 2007, Blood.

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function

H. Deeg, D. Stirewalt, C. Dinarello, 2008, Proceedings of the National Academy of Sciences.

NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.

H. Cohen, C. Gross, R. Jagsi, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Quantitative and stoichiometric analysis of the microRNA content of exosomes

M. Tewari, J. Chevillet, C. Higano, 2014, Proceedings of the National Academy of Sciences.

Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.

L. Beppu, J. Radich, D. Stirewalt, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific.

J. Radich, D. Stirewalt, C. Willman, 2001, Leukemia research.

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

I. Bernstein, J. Radich, R. Arceci, 2003, Blood.

Tumour necrosis factor‐induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?

H. Deeg, J. Radich, D. Stirewalt, 2008, British journal of haematology.

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.

I. Bernstein, S. Raimondi, J. Radich, 2011, Blood.

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia

J. Radich, S. Meshinchi, D. Stirewalt, 2013, PloS one.

Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML

S. Meshinchi, D. Stirewalt, E. Pogosova-Agadjanyan, 2014, Blood Cancer Journal.

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

H. Cohen, C. Gross, R. Jagsi, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Increased AF1q gene expression in high‐risk myelodysplastic syndrome

J. Radich, W. Tse, D. Stirewalt, 2005, British journal of haematology.

Molecular targets in acute myelogenous leukemia.

J. Radich, S. Meshinchi, D. Stirewalt, 2003, Blood reviews.

Single-stranded linear amplification protocol results in reproducible and reliable microarray data from nanogram amounts of starting RNA.

L. Zhao, J. Radich, D. Stirewalt, 2004, Genomics.

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia

R. Ries, S. Meshinchi, T. Alonzo, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of gene expression microarrays for the study of acute leukemia

L. Zhao, J. Radich, D. Stirewalt, 2006, Expert review of molecular diagnostics.

novel biologic clusters for risk classification and outcome prediction Gene expression profiling of adult acute myeloid leukemia identifies

H. Gundacker, J. Radich, D. Ankerst, 2008 .

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia.

Jeremy W. Linsley, J. Radich, M. Slovak, 2006, Blood.

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.

S. Raimondi, J. Radich, N. Heerema, 2009, Blood.

Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia

E. Estey, B. Storer, F. Appelbaum, 2008 .

Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.

S. Raimondi, N. Heerema, S. Meshinchi, 2010, Blood.

Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15.

D. Stirewalt, J. Hansen, E. Petersdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Structural and numerical variation of FLT3/ITD in pediatric AML.

J. Radich, T. Boggon, S. Meshinchi, 2008, Blood.

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.

Brent L Wood, Katherine A Guthrie, Janis L Abkowitz, 2009, Blood.

MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors

S. Meshinchi, D. Stirewalt, Derek L. Stirewalt, 2013, PloS one.

Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets.

D. Goodlett, J. Radich, D. Radulovic, 2012, Journal of proteome research.

Genomic Subtypes of Nucleophosmin (NPM1) Mutations Are Associated with Clinical Outcome in AML - a COG and SWOG Intergroup Collaboration

J. Radich, S. Meshinchi, T. Alonzo, 2016 .

Decreased IRF8 expression found in aging hematopoietic progenitor/stem cells

J. Radich, S. Heimfeld, N. Sharpless, 2009, Leukemia.